Combination dosage form containing a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin

Details for Australian Patent Application No. 2002336419 (hide)

Owner Longwood Pharmaceutical Research, Inc.

Inventors Chungi, Shubha; Iorio, Theodore L

Agent FB Rice

Pub. Number AU-B-2002336419

PCT Number PCT/US02/27877

PCT Pub. Number WO2003/020243

Priority 09/941,948 28.08.01 US

Filing date 28 August 2002

Wipo publication date 18 March 2003

Acceptance publication date 19 July 2007

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/26 (2006.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

A61K 9/30 (2006.01) Medicinal preparations characterised by special physical form - Organic coatings

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/197 (2006.01)

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/401 (2006.01) - Proline

A61K 31/4415 (2006.01) - Pyridoxine, i.e.vitamin B

A61K 31/616 (2006.01)

A61K 31/714 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 09/941,948 28.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002336419

22 April 2004 Amendment Made

  The nature of the amendment is: Amend the invention title to read Combination dosage form containing a cholesterol-lowering agent, a reninangiotensin inhibitor, and aspirin

25 May 2006 Amendment Made

  The nature of the amendment is: Amend the invention title to read Combination dosage form containing a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin

19 July 2007 Application Accepted

  Published as AU-B-2002336419

15 November 2007 Standard Patent Sealed

5 November 2009 Assignment Registered

  Longwood Pharmaceutical Research, Inc. The patent has been assigned to The Brigham and Women's Hospital, Inc.; Massachusetts College of Pharmacy and Health Sciences

21 June 2012 Assignment Registered

  Massachusetts College of Pharmacy and Health Sciences ; The Brigham and Women's Hospital, Inc. The patent has been assigned to The Brigham and Women's Hospital, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002336420-NUCLEIC ACID COMPOSITIONS CONFERRING ALTERED VISUAL PHENOTYPES

2002336418-STOWABLE STEERING WHEEL